![Jean-Marc Bellemin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Marc Bellemin
Chief Executive Officer at
CHIESI Farmaceutici SpA
Net worth: 251 801 $ as of 2026-06-29
Profile
Jean-Marc Bellemin holds the position of CFO & Principal Accounting Officer of Iovance Biotherapeutics, Inc. In the past he was Chief Financial Officer & Executive Vice President for Gritstone Oncology, Inc. and Senior Vice President-Business Solutions at Actelion Pharmaceuticals US, Inc. Mr. Bellemin received an undergraduate degree from Université Paris Dauphine-PSL, a graduate degree from Université Paris II Panthéon Assas and an MBA from ESSEC Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-01 | 60,529 ( 0.01% ) | 251 801 $ | 2026-06-29 |
Jean-Marc Bellemin active positions
| Companies | Position | Start |
|---|---|---|
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Chief Executive Officer | 2026-05-14 |
Former positions of Jean-Marc Bellemin
| Companies | Position | End |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 2025-06-29 |
| GRITSTONE BIO, INC. | Director of Finance/CFO | 2020-12-10 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Corporate Officer/Principal | 2017-11-30 |
Training of Jean-Marc Bellemin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Université Paris Dauphine-PSL
 Université Paris Dauphine-PSL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris II Panthéon Assas
 Université Paris II Panthéon Assas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
- Stock Market
- Insiders
- Jean-Marc Bellemin
Choose MarketScreener 
